Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout
Go back to Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||

